Evidence map›Paper›PMID 24456116›Full record

ArticleJournal of medicinal chemistry2014

Design, synthesis, and characterization of α-ketoheterocycles that additionally target the cytosolic port Cys269 of fatty acid amide hydrolase.

Katerina Otrubova, Benjamin F Cravatt, Dale L Boger

Open access · bronzeAbstract read
In one paragraph

Article in Journal of medicinal chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Katerina OtrubovaDepartment of Chemistry, ‡Chemical Physiology, and §The Skaggs Institute for Chemical Biology, The Scripps Research Institute , 10550 North Torrey Pines Road, La Jolla, California 92037, United States.
Benjamin F Cravatt
Dale L Boger
Scripps Research Institute · US

Funding

STRUCTURAL STUDIES OF FAAHP01DA017259 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI CRAVATT, BENJAMIN F · 2004 to 2013
$10.6M
Modulating Signaling Endocannabinoids and Fatty Acid AmidesR37DA015648 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI DALE L BOGER · 2018 to 2026
$3.8M
Modulating Signaling Endocannabinoids and Fatty Acid AmidesR01DA015648 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI BOGER, DALE L · 2002 to 2017
$3.7M
NIDA NIH HHS DA015648NIDA NIH HHS DA017259NIDA NIH HHS P01 DA017259NIDA NIH HHS R01 DA015648NIDA NIH HHS R37 DA015648
6 · The paper itself

Abstract

A series of α-ketooxazoles incorporating electrophiles at the C5 position of the pyridyl ring of 2 (OL-135) and related compounds were prepared and examined as inhibitors of fatty acid amide hydrolase (FAAH) that additionally target the cytosolic port Cys269. From this series, a subset of the candidate inhibitors exhibited time-dependent FAAH inhibition and noncompetitive irreversible inactivation of the enzyme, consistent with the targeted Cys269 covalent alkylation or addition, and maintained or enhanced the intrinsic selectivity for FAAH versus other serine hydrolases. A preliminary in vivo assessment demonstrates that these inhibitors raise endogenous brain levels of anandamide and other FAAH substrates upon intraperitoneal (i.p.) administration to mice, with peak levels achieved within 1.5-3 h, and that the elevations of the signaling lipids were maintained >6 h, indicating that the inhibitors effectively reach and remain active in the brain, inhibiting FAAH for a sustained period.

Indexed as

AmidohydrolasesAnimalsBrainCatalytic DomainCysteineDrug DesignFatty Acid Amide HydrolasesMaleMiceMice, Inbred C57BLOxazolesRatsStructure-Activity RelationshipAmidohydrolasesCysteineFatty Acid Amide HydrolasesOxazoles

Identifiers

PMID24456116
PMCPMC3940414
OpenAlexW2331239203

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.